 WES MOORE, Governor  Ch. 299  
 
– 1 – Chapter 299  
(House Bill 376 ) 
 
AN ACT concerning  
 
Health Insurance – Diagnostic and Supplemental Examinations and Biopsies  for 
Breast Cancer – Cost–Sharing  
 
FOR the purpose of prohibiting , except under certain circumstances,  insurers, nonprofit 
health service plans, and health maintenance organizations that provide coverage 
for diagnostic and supplemental breast examinations from imposing a copayment, 
coinsurance, or deductible requirement for the examination; requiring the M aryland 
Health Care Commission to study and report on the financial impact of eliminating 
cost–sharing for diagnostic image –guided biopsies for breast cancer;  and generally 
relating to health insurance and diagnostic and supplemental examinations and 
biops ies for breast cancer.  
 
BY adding to  
 Article – Insurance  
Section 15 –814.1  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2022 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article – Insurance  
 
15–814.1.  
 
 (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 
INDICATED . 
 
  (2) (I) “DIAGNOSTIC BREAST EXA MINATION ” MEANS A MEDICALLY 
NECESSARY AND APPROP RIATE EXAMINATION OF  THE BREAST THAT IS U SED TO 
EVALUATE AN  ABNORMALITY THAT IS : 
 
    1. SEEN OR SUSPECTED FR OM A PRIOR SCREENING  
EXAMINATION FOR BREA ST CANCER ; OR 
 
    2. DETECTED BY ANOTHER MEANS OF PRIOR 
EXAMINATION . 
 
Ch. 299  2023 LAWS OF MARYLAND   
 
– 2 –    (II) “DIAGNOSTIC BREAST EXA MINATION ” INCLUDES AN 
EXAMINATION USING DI AGNOSTIC MAMMOGRAPHY , BREAST MAGNETIC RESO NANCE 
IMAGING , OR BREAST ULTRASOUND . 
 
  (3) (I) “SUPPLEMENTAL BREAST E XAMINATION ” MEANS A 
MEDICALLY NECESSARY EXAMINATION OF THE B REAST THAT IS USED T O SCREEN 
FOR BREAST CANCER WH EN: 
 
    1. THERE IS NO ABNORMAL ITY SEEN OR SUSPECTE D 
FROM A PRIOR EXAMINA TION ; AND 
 
    2. THERE IS A PERSONAL OR FAMILY MEDICAL HI STORY 
OR ADDITIONAL FACTOR S THAT MAY INCREASE AN INDIVIDUAL ’S RISK OF BREAST 
CANCER . 
 
   (II) “SUPPLEMENTAL BREAST E XAMINATION ” INCLUDES AN 
EXAMINATION USING BR EAST MAGNETIC RESONANCE IMAGING OR  BREAST 
ULTRASOUND . 
 
 (B) THIS SECTION APPLIES TO: 
 
  (1) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 
PROVIDE COVERAGE FOR  DIAGNOSTIC BREAST EX AMINATIONS OR SUPPLE MENTAL 
BREAST EXAMINATIONS UNDER INDIVIDUAL , GROUP , OR BLANKET HEALT H 
INSURANCE POLICIES O R CONTRACTS THAT ARE  ISSUED OR DELIVERED IN THE 
STATE ; AND 
 
  (2) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 
COVERAGE FOR DIAGNOS TIC BREAST EXAMINATI ONS OR SUPPLEMENTAL BREAST 
EXAMINATIONS UNDER I NDIVIDUAL OR GROUP C ONTRACTS THAT A RE ISSUED OR 
DELIVERED IN THE STATE . 
 
 (C) (1) SUBJECT TO  EXCEPT AS PROVIDED IN  PARAGRAPH (2) OF THIS 
SUBSECTION , AN ENTITY SUBJECT TO  THIS SECTION MAY NOT  IMPOSE A 
COPAYMENT , COINSURANCE , OR DEDUCTIBLE REQUIR EMENT ON COVERAGE FO R 
DIAGNOSTIC BREAST EX AMINA TIONS OR SUPPLEMENTA L BREAST EXAMINATION S. 
 
  (2) IF THE APPLICATION OF  PARAGRAPH (1) OF THIS SUBSECTION T O 
A HEALTH SAVINGS ACC OUNT–QUALIFIED HIGH DEDUC TIBLE HEALTH PLAN WO ULD  
RESULT IN HEALTH SAV INGS ACCOUNT INELIGI BILITY UNDER § 223 OF THE  
INTERNAL REVENUE CODE, PARAGRAPH (1) OF THIS SUBSECTION S HALL APPLY 
ONLY WITH RESPECT TO  THE DEDUCTIBLE OF TH E PLAN AFTER THE ENR OLLEE HAS 
SATISFIED THE MINIMU M DEDUCTIBLE UNDER § 223 OF THE INTERNAL REVENUE 
 WES MOORE, Governor  Ch. 299  
 
– 3 – CODE  IF AN INSURED OR ENRO LLEE IS COVERED UNDE R A HIGH –DEDUCTIBLE 
HEALTH PLAN , AS DEFINED IN 26 U.S.C.  § 223,  AN ENTITY SUBJECT TO  THIS SECTION 
MAY SUBJECT DIAGNOST IC BREAST EXAMINATIO NS OR SUPPLEMENTAL B REAST 
EXAMINATIONS TO THE DEDUCTIBLE REQUIREME NT OF THE HIGH –DEDUCTIBLE 
HEALTH PLAN . 
 
 SECTION 2. AND BE IT F URTHER ENACTED, That on or before October 1, 2023, 
the Maryland Health Care Commission shall study and report to the Governor and, in 
accordance with § 2 –1257 of the State Government Article, the Senate Finance Committee 
and the House Health and Government  Operations Committee, on the financial impact of 
eliminating health insurance cost –sharing for diagnostic image –guided biopsies for breast 
cancer.  
 
 SECTION 3. AND BE IT FURTHER ENACTED, That Section 1 of  this Act shall 
apply to all policies, contracts, and health benefit plans issued, delivered, or renewed in the 
State on or after January 1, 2024.  
 
 SECTION 3. 4. AND BE IT FURTHER ENACTED, That Section 1 of  this Act shall 
take effect January 1, 2024.  
 
 SECTION 5. AND BE IT FURTHER ENACTED, That, except as provided in Section 
4 of this Act, this Act shall take effect July 1, 2023.  
 
Approved by the Governor, May 3, 2023.  